{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-007667","form_type":"8-K","ticker":"DWTX","cik":"0001818844","company_name":"Dogwood Therapeutics, Inc.","filed_at":"2023-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.825427+00:00","generated_at":"2026-06-16T03:46:52.536172+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Virios Therapeutics gets Nasdaq bid-price extension to Oct 30, 2023","bullets":["Received extension letter on May 2, 2023; new compliance period ends Oct 30, 2023.","Company meets all other Nasdaq listing requirements except $1.00 minimum bid price.","Intends to cure deficiency via reverse stock split if necessary.","If not compliant by Oct 30, 2023, Nasdaq could delist; company may appeal to Hearings Panel.","No assurance of regaining compliance or maintaining Nasdaq listing."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-007667","json":"https://secwatch.observer/filing/0001558370-23-007667.json","markdown":"https://secwatch.observer/filing/0001558370-23-007667.md","text":"https://secwatch.observer/filing/0001558370-23-007667.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818844/000155837023007667/0001558370-23-007667-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818844/000155837023007667/tmb-20230502x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T03:46:52.536172+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}